CIK 0001782223
- Emerging growth company
Pyxis Oncology, Inc.
Sign in to watch- Ticker
- PYXS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831160910
- Phone
- +1 617-221-9059
- Business address
- 321 HARRISON AVENUE, BOSTON, MA, 02118
- 4 Open-market buy Director bought 15,700 shares at $12.74 ($200,018)
- 4 Open-market buy Director bought 312,500 shares at $16.00 ($5,000,000)
- 4 Conversion Director acquired 2,388 shares (conversion)
- 4 Conversion Former 10% Owner acquired 2,742,338 shares (conversion)
- 4 Open-market buy Former 10% Owner bought 450,000 shares at $16.00 ($7,200,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Medical Officer acquired 43,750 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 6 of 7 · 126 filings